These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 3121978)
21. [Temporal variation of titers of serologic reactions in the chronic phase of Chagas disease and its possible clinical correlation]. Arteaga-Fernández E; Barreto AC; Ianni BM; Mady C; Bellotti G; Pileggi F Arq Bras Cardiol; 1988 Aug; 51(2):143-6. PubMed ID: 3150802 [No Abstract] [Full Text] [Related]
22. [Transfer of humoral immunity to Trypanosoma cruzi induced by heat in mice]. Guhl F; Marinkelle CJ; de Sánchez N; Grögl M Rev Inst Med Trop Sao Paulo; 1979; 21(4):166-71. PubMed ID: 120975 [No Abstract] [Full Text] [Related]
23. Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response. Cabeza Meckert P; Chambó JG; Laguens RP Antimicrob Agents Chemother; 1988 Feb; 32(2):241-5. PubMed ID: 3129986 [TBL] [Abstract][Full Text] [Related]
24. The effect of lampit on Trypanosoma cruzi in mice organs and in the bloodstream. Villalta F; de Souza W; Leon W Z Parasitenkd; 1979; 61(1):21-7. PubMed ID: 120645 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of tests based on Trypanosoma cruzi excreted-secreted antigens in an endemic area for Chagas' disease in Bolivia. Zarate-Blades CR; Bladés N; Nascimento MS; da Silveira JF; Umezawa ES Diagn Microbiol Infect Dis; 2007 Feb; 57(2):229-32. PubMed ID: 17020793 [TBL] [Abstract][Full Text] [Related]
27. Trypanosoma cruzi: multiplex PCR to detect and classify strains according to groups I and II. Liarte DB; Murta SM; Steindel M; Romanha AJ Exp Parasitol; 2009 Dec; 123(4):283-91. PubMed ID: 19133262 [TBL] [Abstract][Full Text] [Related]
28. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens]. Moretti E; Cervetta L; Basso B; Castro I; Santamarina N Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716 [TBL] [Abstract][Full Text] [Related]
29. Specific immunodiagnosis of Chagas disease: immunodiffusion test using a specific serum anti-Trypanosoma cruzi component 5. Breniere FS; Carlier Y; Carrasco R; Molinedo S; Lemesre JL; Desjeux P; Afchain D Trop Geogr Med; 1987 Jul; 39(3):281-6. PubMed ID: 3124314 [TBL] [Abstract][Full Text] [Related]
30. [Reaction of the Trypanosoma cruzi strain to the experimental therapeutical response to Bay 2502 (results of long term treatment)]. Andrade SG; Figueira RM; Carvalho ML; Gorini DF Rev Inst Med Trop Sao Paulo; 1975; 17(6):380-9. PubMed ID: 815983 [No Abstract] [Full Text] [Related]
31. Test screens blood for parasitic infection. FDA Consum; 2007; 41(2):7. PubMed ID: 17590898 [No Abstract] [Full Text] [Related]
32. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence. Rowland E; Luo H; McCormick T J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970 [TBL] [Abstract][Full Text] [Related]
33. Trypanosoma cruzi: sensitivity of the polymerase chain reaction for detecting the parasite in the blood of mice infected with different clonal genotypes. Miyamoto CT; Gomes ML; Marangon AV; Araújo SM; Bahia MT; Lana M; Toledo MJ Exp Parasitol; 2006 Mar; 112(3):198-201. PubMed ID: 16376332 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of Chagas' disease]. Apt W Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147 [No Abstract] [Full Text] [Related]
35. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Tekiel V; Alba-Soto CD; González Cappa SM; Postan M; Sánchez DO Vaccine; 2009 Feb; 27(9):1323-32. PubMed ID: 19162108 [TBL] [Abstract][Full Text] [Related]
36. Biochemical, immunological, and biological characterization of Trypanosoma cruzi populations of the Andean north of Chile. Gonzalez J; Muñoz S; Ortiz S; Anacona D; Salgado S; Galleguillos M; Neira I; Sagua H; Solari A Exp Parasitol; 1995 Aug; 81(1):125-35. PubMed ID: 7628560 [TBL] [Abstract][Full Text] [Related]
37. Chagas' disease in Bolivia: clinical and epidemiological features and zymodeme variability of Trypanosoma cruzi strains isolated from patients. Brenière SF; Carrasco R; Revollo S; Aparicio G; Desjeux P; Tibayrenc M Am J Trop Med Hyg; 1989 Nov; 41(5):521-9. PubMed ID: 2510524 [TBL] [Abstract][Full Text] [Related]
38. Modification of the pattern of infection and evolution of cardiopathy in experimental Chagas' disease after treatment with immunosuppressive and trypanocidal drugs. Cabeza Meckert PM; Chambó JG; Laguens RP Medicina (B Aires); 1988; 48(1):7-11. PubMed ID: 3063916 [No Abstract] [Full Text] [Related]
39. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs. Carneiro CM; Martins-Filho OA; Reis AB; Veloso VM; Araújo FM; Bahia MT; de Lana M; Machado-Coelho GL; Gazzinelli G; Correa-Oliveira R; Tafuri WL Acta Trop; 2007 Feb; 101(2):120-9. PubMed ID: 17296162 [TBL] [Abstract][Full Text] [Related]
40. In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease. Boiani L; Davies C; Arredondo C; Porcal W; Merlino A; Gerpe A; Boiani M; Pacheco JP; Basombrío MA; Cerecetto H; González M Eur J Med Chem; 2008 Oct; 43(10):2229-37. PubMed ID: 18255195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]